Findacure’s Drug Repurposing for Rare Diseases Conference is back for an eighth year, and this time, it’s gone virtual!
Naturally, this year’s conference will be a little different. COVID-19 has forced us online, but in grabbing the word’s attention, it has also become the poster boy for the power of drug repurposing. In a matter of months, scientists successfully repurposed dexamethasone to treat COVID-19, so why can’t the same urgency be applied to rare diseases?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Findacure’s Drug Repurposing for Rare Diseases Conference is back for an eighth year, and this time, it’s gone virtual!
Naturally, this year’s conference will be a little different. COVID-19 has forced us online, but in grabbing the word’s attention, it has also become the poster boy for the power of drug repurposing. In a matter of months, scientists successfully repurposed dexamethasone to treat COVID-19, so why can’t the same urgency be applied to rare diseases?
Details
Organiser
Venue